X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to milestone payments. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Payment of Upfront Fees No definition available.
|
X | ||||||||||
- Definition The amount of research and development expense payable on achieving milestone targets. No definition available.
|
X | ||||||||||
- Definition Represents the percentage of royalty. No definition available.
|
X | ||||||||||
- Definition The description of terms of clinical research support agreement. No definition available.
|
X | ||||||||||
- Definition The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|